LIP
INO icon

Lighthouse Investment Partners’s Inovio Pharmaceuticals INO Stock Holding History

Lighthouse Investment Partners’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-30,600
Closed -$53.2K – 880
2025
Q4 		$53.2K Buy
+30,600
New +$67.4K ﹤0.01% 850

Other funds holding INO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lighthouse Investment Partners's INO Position: Q1 2026 in Review

Lighthouse Investment Partners sold out of Inovio Pharmaceuticals (INO) in Q1 2026, closing a stake of 30,600 shares — an estimated $53.2K sold.

Lighthouse Investment Partners first reported a position in INO in Q4 2025 and held it in 1 quarter. The position peaked at $53.2K in Q4 2025. 100 funds tracked by Wall St. Rank hold INO as of Q1 2026.

  • Lighthouse Investment Partners reported no remaining Inovio Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Lighthouse Investment Partners sold 30,600 Inovio Pharmaceuticals shares in Q1 2026, an estimated $53.2K.
  • Lighthouse Investment Partners first reported a position in Inovio Pharmaceuticals in Q4 2025 and held it in 1 quarter.
  • Lighthouse Investment Partners's Inovio Pharmaceuticals position peaked at $53.2K in Q4 2025.
  • 100 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q1 2026.

Based on Lighthouse Investment Partners's 13F filing for Q1 2026, filed 14 May 2026.